Advertising Disclaimer
This Article
Right arrow Full Text
Right arrow Full Text (PDF)
Right arrow Alert me when this article is cited
Right arrow Alert me when eLetters are posted
Right arrow Alert me if a correction is posted
Right arrow Citation Map
Services
Right arrow E-mail this article to a friend
Right arrow Similar articles in this journal
Right arrow Similar articles in PubMed
Right arrow Alert me to new issues of the journal
Right arrow Add to My File Cabinet
Right arrow Download to citation manager
Right arrowRequest Permissions
Citing Articles
Right arrow Citing Articles via HighWire
Right arrow Citing Articles via CrossRef
Right arrow Citing Articles via Google Scholar
Google Scholar
Right arrow Search for Related Content
PubMed
Right arrow PubMed Citation
Related Collections
Right arrow Premature & Newborn
Social Bookmarking
Add to CiteULike   Add to Connotea   Add to Del.icio.us   Add to Digg   Add to Facebook   Add to Reddit   Add to Technorati   Add to Twitter  
What's this?

PEDIATRICS Vol. 105 No. 4 April 2000, pp. 880-887

AMERICAN ACADEMY OF PEDIATRICS:
Use of Psychoactive Medication During Pregnancy and Possible Effects on the Fetus and Newborn

Committee on Drugs

Psychoactive drugs are those psychotherapeutic drugs used to modify emotions and behavior in the treatment of psychiatric illnesses. This statement will limit its scope to drug selection guidelines for those psychoactive agents used during pregnancy for prevention or treatment of the following common psychiatric disorders: schizophrenia, major depression, bipolar disorder, panic disorder, and obsessive-compulsive disorder. The statement assumes that pharmacologic therapy is needed to manage the psychiatric disorder. This decision requires thoughtful psychiatric and obstetric advice.

.


Add to CiteULike CiteULike   Add to Connotea Connotea   Add to Del.icio.us Del.icio.us   Add to Digg Digg   Add to Facebook Facebook   Add to Reddit Reddit   Add to Technorati Technorati   Add to Twitter Twitter    What's this?

Statement of reaffirmation:

AAP Publications Retired or Reaffirmed
Pediatrics 121: 647-647. [Full Text]



This article has been cited by other articles:


Home page
 J PsychopharmacolHome page
G. Goodwin and Consensus Group of the British Association for Psy
Evidence-based guidelines for treating bipolar disorder: revised second edition--recommendations from the British Association for Psychopharmacology
J Psychopharmacol, June 1, 2009; 23(4): 346 - 388.
[Abstract] [PDF]

Home page
 J PsychopharmacolHome page
M. Rahi, T. Heikkinen, S. Hartter, J. Hakkola, K. Hakala, O. Wallerman, M. Wadelius, C. Wadelius, and K. Laine
Placental transfer of quetiapine in relation to P-glycoprotein activity
J Psychopharmacol, September 1, 2007; 21(7): 751 - 756.
[Abstract] [PDF]

Home page
 NEJMHome page
C. Louik, A. E. Lin, M. M. Werler, S. Hernandez-Diaz, and A. A. Mitchell
First-Trimester Use of Selective Serotonin-Reuptake Inhibitors and the Risk of Birth Defects
N. Engl. J. Med., June 28, 2007; 356(26): 2675 - 2683.
[Abstract] [Full Text] [PDF]

Home page
 FocusHome page
Gender Differences in the Prescribing of Antipsychotic Drugs
Focus, January 1, 2006; 4(1): 115.


Home page
 Am. J. PsychiatryHome page
M. V. Seeman
Gender Differences in the Prescribing of Antipsychotic Drugs
Am J Psychiatry, August 1, 2004; 161(8): 1324 - 1333.
[Abstract] [Full Text] [PDF]

Home page
 The Annals of PharmacotherapyHome page
S. Gentile
Clinical Utilization of Atypical Antipsychotics in Pregnancy and Lactation
Ann. Pharmacother., July 1, 2004; 38(7): 1265 - 1271.
[Abstract] [Full Text] [PDF]

Home page
 PediatricsHome page
P. S. Zeskind and L. E. Stephens
Maternal Selective Serotonin Reuptake Inhibitor Use During Pregnancy and Newborn Neurobehavior
Pediatrics, February 1, 2004; 113(2): 368 - 375.
[Abstract] [Full Text] [PDF]

Home page
 Arch Gen PsychiatryHome page
K. Laine, T. Heikkinen, U. Ekblad, and P. Kero
Effects of Exposure to Selective Serotonin Reuptake Inhibitors During Pregnancy on Serotonergic Symptoms in Newborns and Cord Blood Monoamine and Prolactin Concentrations
Arch Gen Psychiatry, July 1, 2003; 60(7): 720 - 726.
[Abstract] [Full Text] [PDF]

Home page
 FocusHome page
R. M.A. Hirschfeld, C. L. Bowden, M. J. Gitlin, P. E. Keck, R. H. Perlis, T. Suppes, M. E. Thase, and K. D. Wagner
Practice Guideline for the Treatment of Patients With Bipolar Disorder (Revision)
Focus, January 1, 2003; 1(1): 64 - 110.
[Full Text] [PDF]

Home page
 Pediatr. Rev.Home page
R. J. Boyle
Effects of Certain Prenatal Drugs on the Fetus and Newborn
Pediatr. Rev., January 1, 2002; 23(1): 17 - 24.
[Full Text] [PDF]